Copyright
©The Author(s) 2000.
World J Gastroenterol. Aug 15, 2000; 6(4): 565-568
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.565
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.565
Figure 1 Serum VEGF levels in benign liver tumor and HCC (hepa tocellular carcinoma) groups.
- Citation: Niu Q, Tang ZY, Ma ZC, Qin LX, Zhang LH. Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 2000; 6(4): 565-568
- URL: https://www.wjgnet.com/1007-9327/full/v6/i4/565.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i4.565